SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-10-039795
Filing Date
2010-07-28
Accepted
2010-07-28 16:02:18
Documents
4
Period of Report
2010-07-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v191489_8k.htm 8-K 34296
2 v191489_ex99-1.htm EX-99.1 317450
3 GRAPHIC logo.gif GRAPHIC 3274
4 v191489_ex99-2.htm EX-99.2 394756
  Complete submission text file 0001144204-10-039795.txt   752819
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 10974419
SIC: 2836 Biological Products, (No Diagnostic Substances)